Livzon Pharmaceutical Group's total assets for Q3 2025 were ¥24.54B, an increase of 1.51% from the previous quarter. HK:1513 total liabilities were ¥9.17B for the fiscal quarter, a -0.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.